Goldman Sachs Group Inc Cytosorbents Corp Transaction History

Goldman Sachs Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 14, 2024	BUY	$1.79 - $4.17 $6,707 - $15,624	3,747 Added 32.25%	15,365 $51,000
Q1 2023 May 11, 2023	BUY	$1.79 - $4.17 $27,503 - $64,072	15,365 New	15,365 $51,000
Q3 2022 May 14, 2024	SELL	$1.2 - $2.46 $52,915 - $108,476	-44,096 Reduced 79.15%	11,618 $16,000
Q3 2022 Nov 10, 2022	SELL	$1.2 - $2.46 $52,915 - $108,476	-44,096 Reduced 79.15%	11,618 $0
Q2 2022 May 14, 2024	BUY	$1.76 - $3.22 $98,056 - $179,399	55,714 New	55,714 $122,000
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $427,966 - $782,984	-243,163 Reduced 81.36%	55,714 $122,000
Q1 2022 May 16, 2022	BUY	$2.88 - $4.23 $485,890 - $713,651	168,712 Added 129.61%	298,877 $954,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $8.11 $174,615 - $349,662	43,115 Added 49.53%	130,165 $546,000
Q3 2021 Nov 10, 2021	BUY	$7.0 - $9.71 $609,350 - $845,255	87,050 New	87,050 $707,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.